Abstract
No public abstract is available from the verified source records.
Philip Joseph, Isabelle Johansson Bartolini
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global, regional, and national burden of heart failure, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
Kept as external metadata until matched
Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023.
10.1016/j.jacc.2025.08.015 · 2025
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.
10.1016/s0140-6736(21)01330-1 · 2021
Secondary prevention medications in 17 countries grouped by income level (PURE): a prospective cohort study.
10.1016/j.jacc.2024.10.121 · 2025
Global variations in heart failure etiology, management, and outcomes.
10.1001/jama.2023.5942 · 2023
Polypill with or without aspirin in persons without cardiovascular disease.
10.1056/nejmoa2028220 · 2021
Polypill strategy in secondary cardiovascular prevention.
10.1056/nejmoa2208275 · 2022
A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial.
10.1016/s0140-6736(19)31949-x · 2019
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial.
10.1016/s0140-6736(22)00325-7 · 2022
Trial of an intervention to improve acute heart failure outcomes.
10.1056/nejmoa2211680 · 2023
Coordinating efforts to reduce the global incidence of cardiovascular disease.
10.1056/nejme2309401 · 2023
No additional external references are available.